Research presentation

Femtech’s Challenge: Growth, Gaps, and the Health Equity Imperative

What if half the population’s health needs were an afterthought in global innovation—and what if fixing that presented a hundred-billion-dollar opportunity? Femtech is no longer just about fertility apps; it’s redefining how healthcare serves women across every stage of life. This report dives deep into the data behind the momentum, the money, and the massive market gaps that innovators and investors can no longer afford to ignore.

Get the presentation Discuss the findings

Health Equity Thematic Report Women's Health

Femtech’s Challenge: Growth, Gaps, and the Health Equity Imperative

What if the untapped health needs of half the global population represented a $100B opportunity? Femtech is evolving from niche fertility tools into a powerful driver of inclusive innovation in healthcare. This comprehensive Femtech investment report explores the sector’s rapid evolution, spotlighting high-growth trends, persistent funding inequities, and the pressing need for health equity.

Backed by HealthTech Alpha—Galen Growth’s proprietary platform for global digital health data and market intelligence—this Femtech investment report delivers unmatched, non-hyped, data-driven insights across the ecosystem. From startup traction to investor dynamics, it’s an essential resource for those looking to understand where innovation is happening—and where it’s falling short.

Key Insights Include

Femtech venture growth has surged 3.2x over the last decade, but investment lags at 1.4x growth.
Femtech’s share of global digital health funding dropped to 7.6% in Q1 2025 from 14.7% in 2020.
70% of Femtech startups under six years old remain pre-Series A, highlighting a critical funding bottleneck.
Health system partnerships now surpass pharma deals, accounting for 23% of Femtech collaborations.
M&A is heating up, with 56% of deals occurring between startups, signaling early consolidation.

Ventures and Companies Covered in the Report

The “Femtech Challenge” report includes data on the following companies: Freya Biosciences, Millie, Allara, Orange Health, Oula, Flo Health, Freenome, BillionToOne, Koios Medical, Maven, Foodsmart, Sword Health, Eko Health, BillionToOne, Willow, RH Capital, Amboy Street Ventures, The Case for Her , Great Oaks Venture Capital, The Gates Foundation, GV, General Catalyst

Powered by HealthTech Alpha

Femtech’s Challenge: Growth, Gaps, and the Health Equity Imperative report is powered by HealthTech Alpha, the premier digital health intelligence platform delivering unparalleled data and insights into the evolving healthcare technology landscape. Leveraging an extensive database of over 15,000 ventures and cutting-edge analytics, HealthTech Alpha provides a data-driven foundation to analyse the critical trends shaping the future of digital health.

Designed to empower stakeholders—including investors, pharmaceutical leaders, and medical device manufacturers—HealthTech Alpha offers actionable intelligence to navigate digital transformation complexities. This collaboration ensures readers gain a comprehensive, evidence-based view of the intersection between digital health and healthcare, equipping them to identify strategic opportunities, assess market dynamics, and stay ahead in this fast-evolving industry.

How to Cite This Report

APA: Galen Growth. (2025). Femtech’s Challenge: Growth, Gaps, and the Health Equity Imperative. HealthTech Alpha. https://www.galengrowth.com/product/femtechs-challenge-growth-gaps-and-the-health-equity-imperative/

Short form: Galen Growth / HealthTech Alpha, 2025.

Transform research into action

Build an Alpha Brief from the Health Equity research

Transform this research into a focused intelligence brief customised to your strategic objectives. Answer five quick questions and we will translate the research into a tailored Alpha Brief aligned to the decision, focus area, outcome, success criteria, and timing you need.

What Alpha Briefs are

Tailored intelligence deliverables powered by HealthTech Alpha, AI-enabled analysis, and Galen Growth expertise.

What they are not

Generic report downloads. If additional research or analysis is needed, we may recommend a broader advisory engagement.

1. What decision are you trying to make?

2. What area should we focus on?

3. What outcome would be most valuable?

4. What would make this brief successful?

5. When do you need this insight?

Additional context. (Optional)

Alpha Brief

Request summary

Answer the five Alpha Brief questions. We will prepare a tailored proposal aligned to your objectives.

Complete the five prompts to add your contact details and request the Alpha Brief.

Next step

Want the analysis behind the slides?

Tell us what decision you are trying to make. We can shape the data, company universe, and strategic interpretation around your market, portfolio, partnership, or investment question.

Engage Galen Growth

Femtech’s Challenge: Growth, Gaps, and the Health Equity Imperative

Build an Alpha Brief from the Health Equity research

Want the analysis behind the slides?

Overview

Category

Stage

Total Funding

GGA Score